Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy
- 1 July 1998
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (1) , 151-168
- https://doi.org/10.1016/s0168-8278(98)80191-8
Abstract
No abstract availableThis publication has 122 references indexed in Scilit:
- Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutantsHepatology, 1997
- Lamivudine resistance inimmunocompetent chronic hepatitis BJournal of Hepatology, 1997
- Combination therapy for chronic hepatitis BHepatology, 1997
- Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudineLiver International, 1997
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver tnrasplantation ? A pilot studyHepatology, 1995
- The problem of antiviral therapy for chronic hepadnavirus infectionsJournal of Hepatology, 1993
- Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA templateBiochemical and Biophysical Research Communications, 1992
- Synthesis and encapsidation of duck hepatitis B virus reverse transcriptase do not require formation of core-polymerase fusion proteinsCell, 1989
- Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cellsPublished by Elsevier ,1986